Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.

Secondary antibody deficiencies (SAD) may require immunoglobulin replacement therapy (IgRT). While the intravenous route (IVIG) is broadly considered effective in SAD, the use of subcutaneous immunoglobulins (SCIG) is mainly adopted from the experience in primary antibody deficiencies (PAD), where S...

Full description

Bibliographic Details
Main Authors: Francesco Cinetto, Raffaella Neri, Fabrizio Vianello, Andrea Visentin, Gregorio Barilà, Sabrina Gianese, Alison Lanciarotta, Cinzia Milito, Marcello Rattazzi, Francesco Piazza, Livio Trentin, Renato Zambello, Carlo Agostini, Riccardo Scarpa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247717

Internet

https://doi.org/10.1371/journal.pone.0247717

Similar Items